Epidemiology and aetiology of chronic rhinosinusitis in Asia-A narrative review
- PMID: 35997660
- DOI: 10.1111/coa.13971
Epidemiology and aetiology of chronic rhinosinusitis in Asia-A narrative review
Abstract
Background: Despite having a similar prevalence to Western populations, literature on chronic rhinosinusitis (CRS) in the Asian population is sparse. There is limited data on the epidemiology and aetiology of CRS in Asia.
Objectives: To review the current literature on the epidemiology and aetiology of CRS in Asia.
Methods: This is a narrative review of published data on the epidemiology and aetiology of CRS. Studies on CRS in Asian countries, published in English and indexed on PubMed or Google Scholar were reviewed. Where available, data extracted included epidemiology, endotype and cytokine profiles and genetic profiles.
Results and conclusion: The prevalence of CRS in Asia ranges widely from 2.1% to 28.4%. Type 2 inflammation has been reported in 5%-55% of Asian patients, with lower levels of Type 2 cytokines reported in head to head comparisons of Western versus Asian patients. Notably, there exists marked heterogeneity in criterion of the tissue eosinophilic infiltration for diagnosis of type 2 CRS. Our review suggests that differences in prevalence of CRS and proportion of eosinophilic CRS between Asia and Europe and the Americas requires further study. Large-scale Asian studies utilising standardised definitions are needed to bridge this gap. Head to head genetic and microbiomal analysis may also be useful in understanding differences in CRS between the Asian and Western populations.
Keywords: Asia; aetiology; chronic rhinosinusitis; eosinophilic; microbiome; prevalence; review.
© 2022 John Wiley & Sons Ltd.
Similar articles
-
Immunological mechanisms and treatable traits of chronic rhinosinusitis in Asia: A narrative review.Clin Otolaryngol. 2023 Mar;48(2):363-370. doi: 10.1111/coa.14001. Epub 2022 Nov 13. Clin Otolaryngol. 2023. PMID: 36317525 Review.
-
Chronic rhinosinusitis in Asia.J Allergy Clin Immunol. 2017 Nov;140(5):1230-1239. doi: 10.1016/j.jaci.2017.09.009. Epub 2017 Oct 5. J Allergy Clin Immunol. 2017. PMID: 28987810
-
Chronic rhinosinusitis in Europe--an underestimated disease. A GA²LEN study.Allergy. 2011 Sep;66(9):1216-23. doi: 10.1111/j.1398-9995.2011.02646.x. Epub 2011 May 24. Allergy. 2011. PMID: 21605125
-
Diversity of TH cytokine profiles in patients with chronic rhinosinusitis: A multicenter study in Europe, Asia, and Oceania.J Allergy Clin Immunol. 2016 Nov;138(5):1344-1353. doi: 10.1016/j.jaci.2016.05.041. Epub 2016 Jul 15. J Allergy Clin Immunol. 2016. PMID: 27544740
-
A Decade of Pathogenesis Advances in Non-Type 2 Inflammatory Endotypes in Chronic Rhinosinusitis: 2012-2022.Int Arch Allergy Immunol. 2023;184(12):1237-1253. doi: 10.1159/000532067. Epub 2023 Sep 18. Int Arch Allergy Immunol. 2023. PMID: 37722364 Review.
Cited by
-
Management of chronic rhinosinusitis with nasal polyps in the Asia-Pacific region and Russia: Recommendations from an expert working group.Asia Pac Allergy. 2024 Jun;14(2):77-83. doi: 10.5415/apallergy.0000000000000139. Epub 2024 Apr 4. Asia Pac Allergy. 2024. PMID: 38827258 Free PMC article. Review.
-
Maximizing Postoperative Recovery: The Role of Functional Biomaterials as Nasal Packs-A Comprehensive Systematic Review without Meta-Analysis (SWiM).Pharmaceutics. 2023 May 18;15(5):1534. doi: 10.3390/pharmaceutics15051534. Pharmaceutics. 2023. PMID: 37242776 Free PMC article. Review.
-
Epigenetic modifications in chronic rhinosinusitis with and without nasal polyps.Front Genet. 2023 Jan 9;13:1089647. doi: 10.3389/fgene.2022.1089647. eCollection 2022. Front Genet. 2023. PMID: 36699454 Free PMC article. Review.
-
Evaluating the efficacy of nasal irrigation in postoperative functional endoscopic sinus surgery patients: a systematic review and meta-analysis.Eur Arch Otorhinolaryngol. 2024 Aug;281(8):3903-3913. doi: 10.1007/s00405-024-08535-x. Epub 2024 Mar 16. Eur Arch Otorhinolaryngol. 2024. PMID: 38492009
-
Women suffering from chronic rhinosinusitis in Norway are more likely to take sick leave.PLoS One. 2024 Nov 1;19(11):e0313122. doi: 10.1371/journal.pone.0313122. eCollection 2024. PLoS One. 2024. PMID: 39485771 Free PMC article.
References
REFERENCES
-
- Wahid NW, Smith R, Clark A, Salam M, Philpott CM. The socioeconomic cost of chronic rhinosinusitis study. Rhinology. 2020;58(2):112-25.
-
- Rudmik L. Economics of chronic rhinosinusitis. Curr Allergy Asthma Rep. 2017;17(4):20.
-
- Rudmik L, Smith TL. Quality of life in patients with chronic rhinosinusitis. Curr Allergy Asthma Rep. 2011;11(3):247-52.
-
- Schleimer RP. Immunopathogenesis of chronic rhinosinusitis and nasal polyposis. Annu Rev Pathol. 2017;12:331-57.
-
- Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S, et al. European position paper on rhinosinusitis and nasal polyps 2020. Rhinology. 2020;58(Suppl S29):1-464.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous